# Pharmacokinetic Study Of EPZICOM Tablet

> **NCT00337922** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 8 (—)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Lamivudine / Abacavir Sulfate

## Key facts

- **NCT ID:** NCT00337922
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 8 (—)
- **Last updated:** 2008-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00337922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00337922, "Pharmacokinetic Study Of EPZICOM Tablet". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00337922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*